Gene · 169355
Papers1,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A kynurenine immune-metabolic subtype of depression defined by childhood maltreatment and IDO2: Evidence from multi-omics profiling. | Psychol Med | 2026 | 42803521 | PubTator, text mining | PubMed |
| Pharmacological Modulation of the Tryptophan-kynurenine Pathway by the Intervention of Indoleamine 2,3-dioxygenase 2 (IDO2) and Kynureninase (KYNU) in Ovarian Cancer. | Curr Med Chem | 2026 | 42803175 | PubTator, text mining | PubMed |
| The kynurenine pathway in RNA virus infection: immunometabolic control of antiviral defense and viral persistence. | Front Immunol | 2026 | 42769543 | PubTator, text mining | PubMed |
| Phytochemical Modulation of the Kynurenine Pathway (KYNP) and Its Emerging Mechanistic Insights into Cancer Progression: A Systematic Review. | Int J Mol Sci | 2026 | 42737416 | PubTator, text mining | PubMed |
| Compensatory pathways in tryptophan metabolism and immune regulation following IDO inhibition. | Mol Biol Rep | 2026 | 42730796 | PubTator, text mining | PubMed |
| A Di-Rhamnolipid (Rha2-C10-C10) Inhibits Colorectal Cancer Motility and Immune Evasion Through AKT-Associated Signaling and PD-L1 Regulation. | Biofactors | 2026 | 42420774 | PubTator, text mining | PubMed |
| Astilbin ameliorates hyperuricemia-associated renal injury in geese with gut-linked kynurenic acid immunometabolic remodeling. | Int Immunopharmacol | 2026 | 42320251 | PubTator, text mining | PubMed |
| MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy. | Funct Integr Genomics | 2026 | 42307804 | PubTator, text mining | PubMed |
| Synergistic immunomodulatory combinations induce robust human tolerogenic dendritic cells for antigen-specific regulatory T cell generation. | J Pharmacol Exp Ther | 2026 | 42184694 | PubTator, text mining | PubMed |
| EHR Sampling Interval Bias Detection and Burden of Blood Pressure Excursions: Implications for Clinical Decision Support and Model Validity in Pediatric ECMO. | Information (Basel) | 2026 | 42039933 | PubTator, text mining | PubMed |
| Nexus of IDO1/Kynurenine Pathway to T-Cell Exhaustion: Hypoxia-Induced Tryptophan Metabolism in Glioblastoma. | Metabolites | 2026 | 41893336 | PubTator, text mining | PubMed |
| Urinary Tryptophan-Kynurenine Pathway Profiling in Bulgarian Children with Autism Spectrum Disorder (ASD): Neopterin Co-Varies with Kynurenine and Quinolinic Acid. | Metabolites | 2026 | 41893320 | PubTator, text mining | PubMed |
| Integrated metabolomic and transcriptomic analysis reveals novel plasma biomarkers and metabolic pathway dysregulation in latent tuberculosis infection. | Microbiol Spectr | 2026 | 41891697 | PubTator, text mining | PubMed |
| Discovery of triazole analogues as selective IDO1 inhibitors: Dual mechanistic effects on kynurenine pathway suppression and apoptosis in cancer cells. | Bioorg Chem | 2026 | 41856068 | PubTator, text mining | PubMed |
| Artemether and Euphorbia factor L9 suppress kynurenine production through distinct effects on tryptophan metabolism. | Biochem J | 2026 | 41823303 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Human IDO2 exhibits unique binding affinities distinct to those of human IDO1. | FEBS J | 2026 | 41804238 | PubTator, text mining | PubMed |
| Genebody specific epigenomic reprogramming of transcriptome promotes immune evasion in oropharyngeal cancer patients in North-Eastern India. | Clin Epigenetics | 2026 | 41796351 | PubTator, text mining | PubMed |
| The Gut Microbiota-Tryptophan-Brain Axis in Autism Spectrum Disorder: A New Frontier for Probiotic Intervention. | Microorganisms | 2026 | 41753599 | PubTator, text mining | PubMed |
| Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration. | Life (Basel) | 2026 | 41752903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/169355/papers